共 125 条
[1]
Salem R(2011)Research reporting standards for radioembolization of hepatic malignancies J Vasc Interv Radiol 22 265-278
[2]
Lewandowski RJ(2011)Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times Gastroenterology 141 526-535
[3]
Gates VL(2012)Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers Am J Clin Oncol 35 167-177
[4]
Nutting CW(2011)Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience Int J Surg Oncol 2011 571261-1591
[5]
Murthy R(2007)Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab J Vasc Interv Radiol 18 1588-23
[6]
Rose SC(2007)Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 13-1563
[7]
Memon K(2009)Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study J Vasc Interv Radiol 20 1557-1033
[8]
Kulik L(2000)Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy Phys Med Biol 45 1023-1639
[9]
Lewandowski RJ(2005)Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 1627-592
[10]
Wang E(2007)Radioembolization with 90Y microspheres: angiographic and technical considerations Cardiovasc Intervent Radiol 30 571-216